Dolby Laboratories (DLB) Tops Q4 EPS by 10c, Offers Q1 & FY16 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- US stock futures muted as oil holds near April highs ahead of Fed decision
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- CAE agrees to sell Flightscape unit to SITA for $500 million
Dolby Laboratories (DLB) Reports 4Q EPS Miss; B. Riley Cuts Price target to $41
October 22, 2015 9:31 AM EDTB. Riley maintained a Neutral rating on Dolby Laboratories (NYSE: DLB), and cut the price target to $41.00 (from $42.50), following the company's 4Q15 earnings results. Revenues of $229.5MM missed consensus of $235.8MM, and the low-end of the $230-240MM guidance. EPS came in at $0.27 compared to... More



